EdgarLookup

Great Elm Capital Corp. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Great Elm Capital Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
2.02x
Debt-to-Equity
Total liabilities ÷ equity

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 ($2.82M) Mar 2, 2026
FY2025 Dec 31, 2024 ($82.67M) Mar 2, 2026
FY2025 Dec 31, 2023 $25.68M Mar 2, 2026
FY2024 Dec 31, 2022 ($41.76M) Mar 10, 2025
FY2023 Dec 31, 2021 ($58.49M) Feb 29, 2024
FY2022 Dec 31, 2020 $27.39M Mar 2, 2023

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $340.78M Mar 2, 2026
FY2025 Dec 31, 2024 $342.03M Mar 2, 2026
FY2024 Dec 31, 2023 $246.83M Mar 10, 2025
FY2023 Dec 31, 2022 $310.11M Feb 29, 2024
FY2022 Dec 31, 2021 $426.31M Mar 2, 2023

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $227.83M Mar 2, 2026
FY2025 Dec 31, 2024 $205.92M Mar 2, 2026
FY2024 Dec 31, 2023 $148.09M Mar 10, 2025
FY2023 Dec 31, 2022 $225.30M Feb 29, 2024
FY2022 Dec 31, 2021 $351.76M Mar 2, 2023

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $112.95M Mar 2, 2026
FY2025 Dec 31, 2024 $136.11M Mar 2, 2026
FY2024 Dec 31, 2023 $98.74M Mar 10, 2025
FY2023 Dec 31, 2022 $84.81M Feb 29, 2024
FY2022 Dec 31, 2021 $74.56M Mar 2, 2023

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $14.89M Mar 10, 2025
FY2024 Dec 31, 2023 $11.40M Mar 10, 2025
FY2024 Dec 31, 2022 $13.02M Mar 10, 2025
FY2023 Dec 31, 2021 $9.74M Feb 29, 2024

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.83M Mar 2, 2026
FY2024 Dec 31, 2024 $0 Mar 10, 2025
FY2024 Dec 31, 2023 $953.0K Mar 10, 2025
FY2023 Dec 31, 2022 $587.0K Feb 29, 2024
FY2023 Dec 31, 2021 $9.13M Feb 29, 2024
FY2022 Dec 31, 2020 $52.58M Mar 2, 2023

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (2) Mar 2, 2026
FY2025 Dec 31, 2024 0 Mar 2, 2026
FY2025 Dec 31, 2023 3 Mar 2, 2026
FY2024 Dec 31, 2022 (2) Mar 10, 2025
FY2023 Dec 31, 2021 (2) Feb 29, 2024
FY2022 Dec 31, 2020 (14) Mar 2, 2023

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 (2) Mar 2, 2026
FY2025 Dec 31, 2024 0 Mar 2, 2026
FY2025 Dec 31, 2023 3 Mar 2, 2026
FY2024 Dec 31, 2022 (2) Mar 10, 2025
FY2023 Dec 31, 2021 (2) Feb 29, 2024
FY2022 Dec 31, 2020 (14) Mar 2, 2023

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 14.00M Mar 2, 2026
FY2025 Dec 31, 2024 11.54M Mar 2, 2026
FY2025 Dec 31, 2023 7.60M Mar 2, 2026
FY2025 Dec 31, 2022 7.60M Mar 2, 2026
FY2025 Dec 31, 2021 4.48M Mar 2, 2026
FY2023 Dec 31, 2020 3.84M Feb 29, 2024
FY2022 Dec 31, 2019 1.68M Mar 2, 2023